Gene therapy, radiation combination holds promise against prostate cancer

A novel approach that combines gene therapy and radiation therapy for treating prostate cancer has shown promising safety and efficacy results, according to a small study from Henry Ford Hospital in Detroit.

Related Videos

Related Content

Advertisement

December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 23rd 2024

FDA approves vibegron for OAB symptoms in pharmacologically treated BPH

Hannah Clarke

The approval of vibegron is supported by data from the phase 3 COURAGE trial.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 20th 2024

FDA reports Urgent Field Safety Notice on mini PCNL sheath

Hannah Clarke

The alert was issued to clarify that the devices should not be used for suction and irrigation.

December 20th 2024

PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer

Hannah Clarke

The investigators found a positive correlation between PSA levels and SUVmax.

Related Content

Advertisement

December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 23rd 2024

FDA approves vibegron for OAB symptoms in pharmacologically treated BPH

Hannah Clarke

The approval of vibegron is supported by data from the phase 3 COURAGE trial.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 20th 2024

FDA reports Urgent Field Safety Notice on mini PCNL sheath

Hannah Clarke

The alert was issued to clarify that the devices should not be used for suction and irrigation.

December 20th 2024

PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer

Hannah Clarke

The investigators found a positive correlation between PSA levels and SUVmax.